Regal Partners’s Radiopharm Theranostics RADX Stock Holding History

Regal Partners’s Portfolio RADX Stock Details RADX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$173K	Sell	40,138 -50,771	-56%	-$248K	0.01%	106
2025 Q4	$475K	Hold	90,909	–	–	0.03%	86
2025 Q3	$502K	Hold	90,909	–	–	0.04%	65
2025 Q2	$422K	Hold	90,909	–	–	0.04%	50
2025 Q1	$437K	Hold	90,909	–	–	0.04%	39
2024 Q4	$408K	Buy	+90,909	New	+$598K	0.04%	49

Other funds holding RADX

SCM

Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return

Regal Partners's RADX Position: Q1 2026 in Review

Regal Partners reduced its Radiopharm Theranostics (RADX) stake by 56% in Q1 2026, selling an estimated $248K and leaving 40,138 shares worth $173K. The position accounts for 0.01% of the portfolio, ranked #106.

Regal Partners first reported a position in RADX in Q4 2024 and has held it in 6 quarters since. The position peaked at $502K in Q3 2025. 7 funds tracked by Wall St. Rank hold RADX as of Q1 2026.

Regal Partners held 40,138 shares of Radiopharm Theranostics worth $173K as of Q1 2026.
Regal Partners sold 50,771 Radiopharm Theranostics shares in Q1 2026, an estimated $248K.
Radiopharm Theranostics made up 0.01% of Regal Partners's portfolio in Q1 2026, its #106 holding.
Regal Partners first reported a position in Radiopharm Theranostics in Q4 2024 and has held it in 6 quarters since.
Regal Partners's Radiopharm Theranostics position peaked at $502K in Q3 2025.
7 funds tracked by Wall St. Rank held Radiopharm Theranostics as of Q1 2026.

Based on Regal Partners's 13F filing for Q1 2026, filed 15 May 2026.